The Johnson & Johnson booster would be available for all of the nearly 15 million people ages 18 and up who received that vaccine. That’s a departure from the recommendations for Pfizer-BioNTech and Moderna boosters, which are limited to those aged 65 and up, aged 18 to 64 with either underlying health conditions, or whose job that puts them at high risk of exposure to COVID-19.
In fact, many committee members argued that Johnson & Johnson’s vaccination regime should simply be considered a two-dose vaccine, just like the Pfizer and Moderna vaccines, rather than a single shot plus a booster. That drew particularly pointed criticism from the FDA. Dr. Peter Marks, the director of the agency’s Center for Biologics Evaluation and Research, went as far as to suggest that the company was not presenting the full picture, particularly in terms of the real-world effectiveness of a single dose.72% effective against moderate to severe illness
Can't wait to read about the execs in the FDA selling their J&J stocks in a few months.
Get vaccinated, wear a mask, social distance and go about your business safely. Why? B/c there's just no getting around it. It's up to all of us to choose to come together to stop the spread to end the pandemic. Sometimes you just gotta do what you gotta do. Just do right.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisory group recommends 2nd J&J shotDoes the Johnson & Johnson need a booster? The FDA advisory committee recommended a second dose at least two months after the first shot. The second dose of the Johnson & Johnson vaccine would be offered at least 2 months after the first.
Source: NBCNews - 🏆 10. / 86 Read more »
Independent FDA panel votes to authorize Moderna booster for seniors and high-risk AmericansBREAKING: An independent FDA advisory panel voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus. CrystalCOdoms40YearsOldPfizerVaccinated Stock price must've been down.
Source: ABC - 🏆 471. / 51 Read more »
FDA panel debates lower-dose Moderna COVID shots for boosterU.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. Oh wow this is pretty worrisome. The first science didn’t science good so let’s get some different science Sounds like science
Source: AP - 🏆 728. / 51 Read more »
FDA panel endorses lower-dose Moderna COVID shot for boosterU.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19. 🤔🤣🤣 Follow the $$ Interesting. Johnson & Johnson where u at?
Source: AP - 🏆 728. / 51 Read more »
FDA panel unanimously endorses Moderna boosters for certain populationsMembers of the Food and Drug Administration’s vaccine expert panel on Thursday endorsed boosters for Moderna recipients who are at high risk of severe COVID-19, occupational exposure to COVID-19 or are 65 years and older.Why it matters: The unanimous decision mirrors the FDA conditions for those who qualify for a Pfizer booster.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeBe smart: Despite small data sample sizes and limited data, the agency
Source: YahooNews - 🏆 380. / 59 Read more »